Driving research of Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME / CFS),
Post Treatment Lyme Disease Syndrome (PTLDS), and Fibromyalgia.

Metabolic Trap Study

Study Aim

Beginning in 2018, the aim of this study was to test the hypothesis developed by Dr Phair that a crucial component of metabolism in ME / CFS patients appears to be “trapped” in an unhealthy state.

LEAD INVESTIGATORS
  • Robert D. Phair, PhD
  • Julie Wilhelmy, PhD
  • Ronald W. Davis, PhD
UPDATES AND POTENTIAL
 

STUDY HYPOTHESIS AND DESCRIPTION

Biomolecules - Metabolism

The metabolic trap theory emerged from the genetic and metabolomics data from the Severely ill Patients Study (SIPS). Using previously published work, Dr Phair has developed a computational program that can model the flow of metabolism throughout the body and its cells.  Using this technology, Dr Phair can determine any points that may disrupt the flow using genomic and metabolic information and this has led to the hypothesis of a metabolic trap that occurs in ME / CFS patients at the point in metabolism where tryptophan is converted to serotonin and kynurenine.

STUDY DESIGN

To test the hypothesis, experiments were initiated to measure the levels of tryptophan and kynurenine in cells from ME / CFS patients. This is a complicated procedure, as taking cells out of the body without disrupting their inherent metabolism is fraught with problems.

Stay Informed

Be the first to hear our research news.

Subscribe Now.

No thanks